Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.273
AS - Asia 5.937
EU - Europa 5.697
SA - Sud America 779
AF - Africa 95
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 21
Totale 23.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.974
SG - Singapore 2.226
CN - Cina 1.672
DE - Germania 1.036
HK - Hong Kong 941
RU - Federazione Russa 927
SE - Svezia 866
IE - Irlanda 676
IT - Italia 665
BR - Brasile 644
UA - Ucraina 551
VN - Vietnam 402
GB - Regno Unito 329
CA - Canada 227
FI - Finlandia 146
IN - India 138
FR - Francia 122
AT - Austria 114
KR - Corea 114
ID - Indonesia 87
DK - Danimarca 67
AR - Argentina 64
JP - Giappone 64
BD - Bangladesh 54
TR - Turchia 52
ZA - Sudafrica 50
MX - Messico 48
NL - Olanda 46
PL - Polonia 39
ES - Italia 30
IR - Iran 26
IQ - Iraq 25
EC - Ecuador 24
MY - Malesia 23
BE - Belgio 21
NZ - Nuova Zelanda 19
EU - Europa 18
AU - Australia 17
EG - Egitto 16
LT - Lituania 16
SA - Arabia Saudita 14
KZ - Kazakistan 13
PY - Paraguay 12
PK - Pakistan 11
AE - Emirati Arabi Uniti 9
CO - Colombia 9
CZ - Repubblica Ceca 9
UY - Uruguay 9
JO - Giordania 7
KE - Kenya 7
UZ - Uzbekistan 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
IL - Israele 6
VE - Venezuela 6
AL - Albania 5
BH - Bahrain 5
CL - Cile 5
HR - Croazia 5
MA - Marocco 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
TN - Tunisia 5
AZ - Azerbaigian 4
HU - Ungheria 4
PE - Perù 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
MD - Moldavia 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TO - Tonga 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
Totale 23.832
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Singapore 1.392
Hong Kong 919
Woodbridge 819
Ashburn 790
Chandler 706
Dublin 654
Jacksonville 547
Houston 534
Fairfield 456
Frankfurt am Main 453
Wilmington 448
Dearborn 424
Dallas 334
New York 323
Milan 263
Santa Clara 258
Beijing 254
Princeton 244
Seattle 179
Nanjing 177
Boardman 171
Los Angeles 161
Cambridge 137
Shanghai 132
Hefei 119
Vienna 109
Ho Chi Minh City 99
Lachine 89
Buffalo 82
Chicago 82
Dong Ket 78
The Dalles 77
Guangzhou 75
Moscow 74
Altamura 73
Lawrence 71
Jakarta 69
Seoul 60
Nanchang 59
Munich 54
Council Bluffs 53
Hanoi 50
São Paulo 49
Toronto 48
Fremont 45
Shenyang 43
Andover 42
Grafing 40
Jinan 40
Jiaxing 36
Zhengzhou 34
Nürnberg 33
San Diego 32
Changsha 30
Tianjin 30
Helsinki 29
Rio de Janeiro 28
Tokyo 28
Phoenix 27
Brooklyn 26
Columbus 26
Falls Church 26
Ottawa 26
Pune 25
Daejeon 24
Hangzhou 24
Johannesburg 24
Denver 23
Kunming 23
London 23
Mountain View 23
Hebei 22
Montreal 22
Brussels 20
Nuremberg 20
Ankara 19
Sacramento 19
Turku 19
Warsaw 19
Philadelphia 18
Boston 17
Chennai 17
Atlanta 16
Leawood 16
Mexico City 16
Ningbo 16
Rome 16
Orem 15
Poplar 15
Stockholm 15
Edmonton 13
Huizen 13
Bergamo 12
Carate Brianza 12
Da Nang 12
Dhaka 12
Norwalk 12
Pasir Mas 12
Regensburg 12
Totale 15.381
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 415
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 382
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 372
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 365
Age-related changes in the function and structure of the peripheral sensory pathway in mice 365
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 365
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 328
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 311
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 310
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 305
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 299
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 277
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 273
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 269
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 267
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 266
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 264
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 263
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 261
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 256
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 255
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 253
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 250
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 249
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 246
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 244
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 243
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 242
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 237
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 237
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 234
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 229
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 225
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 224
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 223
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 220
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 216
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 216
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 216
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 215
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 215
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 215
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 214
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 213
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 212
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 212
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 210
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 207
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 206
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 206
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 203
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 203
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 203
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 202
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 200
Multimodal experimental approach to the study of human neurological diseases 200
Lipoplatin tm: a less neurotoxic formulation of cisplatin 199
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 198
Erythropoietin both protects from and reverses experimental diabetic neuropathy 197
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 196
Granulocytes in actively induced Lewis rat EAE 192
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 189
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 187
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 185
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 185
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 184
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 184
Effect of proteasome inhibition on the central and peripheral nervous system 184
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 183
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 180
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 180
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 180
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 178
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 178
Regression of diabetic complications by islet transplantation in the rat 177
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 176
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 175
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 174
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 172
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 171
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 171
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 167
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 166
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 166
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 165
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 163
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 160
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 158
Biodistrubution and toxicology of two PFCs intravenously injected in rats 157
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 157
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 156
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 155
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 152
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 152
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 147
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 145
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 143
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 142
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 141
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 140
Totale 21.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.426 0 0 0 0 0 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20254.492 283 607 355 210 350 119 203 169 477 616 416 687
2025/20264.988 1.143 684 911 923 1.173 154 0 0 0 0 0 0
Totale 24.744